Month: <span>November 2020</span>

Home / 2020 / November
How the immune system deals with the gut’s plethora of microbes
Post

How the immune system deals with the gut’s plethora of microbes

by  Rockefeller University A large, multi-colored collection of germinal centers observed in the mesenteric lymph node of a mouse. The gut is an unusually noisy place, where hundreds of species of bacteria live alongside whatever microbes happen to have hitched a ride in on your lunch. Scientists have long suspected that the gut’s immune system, in...

Post

Muscle pain and energy-rich blood: Cholesterol medicine affects the organs differently

UNIVERSITY OF COPENHAGEN THE FACULTY OF HEALTH AND MEDICAL SCIENCES 600,000 Danes take medicine containing statins. Statins lower the cholesterol level and thus helps prevent cardiovascular disease and blood clots. But there is a different side to the coin. Treatment with statins may also have negative side effects, some of which are so severe that...

Post

Some COVID-19 “long haulers” experience lasting skin problems

MASSACHUSETTS GENERAL HOSPITAL BOSTON – Some patients with COVID-19 have persistent skin-related symptoms long after their initial infection has cleared, according to a new analysis. The findings, presented at the 29th Congress of the European Academy of Dermatology and Venereology by investigators at Massachusetts General Hospital (MGH), point to another burden experienced by so-called “long...

SoundWatch Alerts Deaf Users of Nearby Activity
Post

SoundWatch Alerts Deaf Users of Nearby Activity

OCTOBER 29TH, 2020   CONN HASTINGS  ENT, REHAB Researchers at the University of Washington have developed a watch that can monitor a user’s environment for important sounds, such as a fire alarm or a microwave beeping, identify the sounds, and then inform the user through a subtle vibration. “This technology provides people with a way to experience sounds that...

The ‘very, very bad look’ of remdesivir, the first FDA-approved
Post

The ‘very, very bad look’ of remdesivir, the first FDA-approved

President Donald Trump and Food and Drug Administration Commissioner Stephen Hahn (right) met with Daniel O’Day (left), CEO of Gilead Sciences, when remdesivir received an emergency use authorization in May. October was a good month for Gilead Sciences, the giant manufacturer of antivirals headquartered in Foster City, California. On 8 October, the company inked an...

India’s COVID-19 cases have declined rapidly—but herd immunity is still far away
Post

India’s COVID-19 cases have declined rapidly—but herd immunity is still far away

A health worker takes a swab sample from a man to test for COVID-19 outside a garment shop in Mumbai. MUMBAI—Last week, a panel of leading scientists appointed by the Indian government delivered a startlingly optimistic message: The world’s second largest COVID-19 epidemic has rounded a corner. India’s daily number of daily new cases has...

Why scientists and public health officials need to address vaccine mistrust instead of dismissing it
Post

Why scientists and public health officials need to address vaccine mistrust instead of dismissing it

Recent polls indicate that more than a third of the country has concerns about a vaccine that in all likelihood will be the only reliable way to end to the COVID-19 pandemic. These results reflect a similar public sentiment in the U.S. in the 1950s when a polio vaccine was introduced. There are likely multiple reasons for this suspicion,...

Melding biology and physical sciences yields deeper understanding of cancer
Post

Melding biology and physical sciences yields deeper understanding of cancer

by  Massachusetts General Hospital Killer T cells surround a cancer cell. An evolving understanding of cancer that incorporates the physical properties of tumors and their surrounding tissues into existing biologic and genetic models can direct cancer researchers down previously uncharted avenues, potentially leading to new drugs and new treatment strategies, say investigators from Massachusetts General Hospital...

Blood test predicts ovarian cancer better than previously thought
Post

Blood test predicts ovarian cancer better than previously thought

by  University of Exeter Credit: CC0 Public Domain A blood test already available to GPs in the UK is more predictive of ovarian cancer than previously thought and could also help pick up other forms of cancer, according to new research published in PLOS Medicine today (Wednesday) and funded by Cancer Research UK and NIHR. This study involving...